Search
Physician Excellence in Cancer Care Awards
… status quo, and leads with clarity and courage. "Dr. Emese Zsiros has a rare and remarkable ability to transform vision … bold vision and innovation.” Bio Reference Emese Zsiros, MD, PhD, FACOG Professor of Oncology Shashi Lele, MD, … Department of Gynecologic Oncology Meet the nominees Emese Zsiros, MD, PhD, FACOG Kenan Onel, MD, PhD Khurshid Guru, MD …
Page with Layout
Medical Therapy for Cervical Cancer
… Medical Therapy for Cervical Cancer Dr. Emese Zsiros has extensive knowledge in the immuntherapy treatment … of treatments best for you and your cancer. Dr. Emese Zsiros has extensive knowledge in the immuntherapy treatment …
Blog Post
Cancer Innovations: Prioritizing quality of life while treating cancer
News
Roswell Park Team Assesses Addition of Complement Inhibitor Drug to Immunotherapy for Ovarian Cancer
News
Roswell Park Researchers Uncover Clues to Immunotherapy Response in Patients with Recurrent Ovarian Cancer
Blog Post
Cancer Innovations: New initiative reduced prescribed opioids by 45%
Cancer Types
Recurrent Ovarian Cancer
Clinical Trial
A Phase I First-In-Human, Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors
Clinical Trial
A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY FOR LNCB74, A B7-H4 TARGETED ANTIBODY DRUG CONJUGATE, AS MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
Page with Layout
McLean Laboratory Publications
… JAMA , September 2025 Authors: Frederick PJ, Seshadri M, Zsiros E, McLean K. Citation: 2025;334(17):1511–1512. … 41334034; PMCID: PMC12668522. Frederick PJ, Seshadri M, Zsiros E, McLean K. Reflections on Medical Trainee Unions and … Stewart D, Thaker PH, Vargas R, Hendrickson AW, Werner TL, Zsiros E, Dwyer MA, Hang L. NCCN Guidelines® Insights: …